Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
39029742 | 0 | Levy JH, Shaw JR, Castellucci LA, et al. Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. J Thromb Haemost. 2024 Jul 17:S1538-7836(24)00426-4. doi: 10.1016/j.jtha.2024.07.009. | |
38938844 | 0 | Godoy LC, Neal MD, Goligher EC, et al. Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19. JACC Adv. 2024 Jan 26;3(3):100780. doi: 10.1016/j.jacadv.2023.100780. eCollection 2024 Mar. | |
38904133 | 0 | Mai V, Girardi L, de Wit K, et al. Chronic obstructive pulmonary disease exacerbation purulence status and its association with pulmonary embolism: protocol for a systematic review with meta-analysis. BMJ Open. 2024 Jun 19;14(6):e085328. doi: 10.1136/bmjopen-2024-085328. | |
38878942 | 0 | Shurrab M, Austin PC, Jackevicius CA, et al. Comparative Effectiveness and Safety of Apixaban and Rivaroxaban in Older Patients with Atrial Fibrillation: A Population-Based Cohort Study. Heart Rhythm. 2024 Jun 13:S1547-5271(24)02686-9. doi: 10.1016/j.hrthm.2024.06.010. | |
38582384 | 0 | Potere N, Mahe I, Angchaisuksiri P, et al. Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: A global survey. J Thromb Haemost. 2024 Apr 4:S1538-7836(24)00177-6. doi: 10.1016/j.jtha.2024.03.019. | |
37910528 | 0 | Shaw JR, James T, Douxfils J, et al. Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literature. PLoS One. 2023 Nov 1;18(11):e0293632. doi: 10.1371/journal.pone.0293632. eCollection 2023. | |
37854455 | 0 | Walborn AT, Heath A, Neal MD, et al. Effects of inflammation on thrombosis and outcomes in COVID-19: secondary analysis of the ATTACC/ACTIV-4a trial. Res Pract Thromb Haemost. 2023 Sep 16;7(7):102203. doi: 10.1016/j.rpth.2023.102203. eCollection 2023 Oct. | |
37838241 | 0 | Malerba SA, Fumagalli RM, Ay C, et al. Availability of medical and endovascular therapies for venous thromboembolism: A global survey for World Thrombosis Day. J Thromb Haemost. 2023 Oct 12:S1538-7836(23)00765-1. doi: 10.1016/j.jtha.2023.10.002. | |
37597893 | 0 | St Germain L, De Paula E, Ay C, et al. Moving against thrombosis: ISTH recognizes 10th anniversary of World Thrombosis Day and the leaders in the field who led the way - in memory of Claire McLintock, MD, World Thrombosis Day Steering Committee Vice Chair 2019 to 2022. J Thromb Haemost. 2023 Sep;21(9):2311-2312. doi: 10.1016/j.jtha.2023.06.006. | |
36942550 | 0 | Goligher EC, Lawler PR, Jensen TP, et al. Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19. JAMA. 2023 Apr 4;329(13):1066-1077. doi: 10.1001/jama.2023.3651. | |
36921919 | 0 | Whitworth H, Amankwah EK, Betensky M, et al. Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: Communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis. J Thromb Haemost. 2023 Mar 13:S1538-7836(23)00230-1. doi: 10.1016/j.jtha.2023.03.004. | |
36796485 | 0 | Barnes GD, Ageno W, Castellucci LA, et al. Recommendation on the Nomenclature for Anticoagulants: Updated Communication from the ISTH SSC Subcommittee on the Control of Anticoagulation. J Thromb Haemost. 2023 Feb 14:S1538-7836(23)00149-6. doi: 10.1016/j.jtha.2023.02.008. | |
36696204 | 0 | Shaw JR, Castellucci LA, Siegal D, et al. DOAC-associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature. J Thromb Haemost. 2023 Mar;21(3):433-452. doi: 10.1016/j.jtha.2022.11.029. Epub 2022 Dec 22. | |
35679460 | 0 | Wells PS, Tritschler T, Khan F, et al. Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism. Blood Adv. 2022 Jun 9. pii: 485510. doi: 10.1182/bloodadvances.2022007027. | |
34826190 | 0 | Wendelboe AM, Langenfeld H, Ageno W, et al. Current practices of standardized risk assessment for venous thromboembolism: results from a global survey from the World Thrombosis Day steering committee. J Thromb Haemost. 2021 Nov 26. doi: 10.1111/jth.15608. | |
34822215 | 0 | Forgo G, Micieli E, Ageno W, et al. An update on the global use of risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses from the World Thrombosis Day steering committee: systematic review and meta-analysis. J Thromb Haemost. 2021 Nov 25. doi: 10.1111/jth.15607. | |
34742140 | 0 | Nayak AL, Zahrai A, Mallick R, et al. Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trial. Thromb Res. 2021 Oct 26;208:79-82. doi: 10.1016/j.thromres.2021.10.018. | |
34649864 | 0 | Sholzberg M, Tang GH, Rahhal H, et al. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ. 2021 Oct 14;375:n2400. doi: 10.1136/bmj.n2400. | |
34636806 | 0 | Tran A, Fernando SM, Rochwerg B, et al. Prognostic Factors Associated With Development of Venous Thromboembolism in Critically Ill Patients-A Systematic Review and Meta-Analysis. Crit Care Med. 2021 Oct 12. pii: 00003246-900000000-95047. doi: 10.1097/CCM.0000000000005382. | |
34427894 | 0 | Hendin A, Castellucci L, Rosenberg H. Just the facts: how to assess for cerebral venous thrombosis. CJEM. 2021 Aug 24. pii: 10.1007/s43678-021-00194-9. doi: 10.1007/s43678-021-00194-9. | |
34351722 | 0 | Goligher EC, Bradbury CA, McVerry BJ, et al. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):777-789. doi: 10.1056/NEJMoa2103417. Epub 2021 Aug 4. | |
34351721 | 0 | Lawler PR, Goligher EC, Berger JS, et al. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4. | |
34263098 | 0 | Barco S, Valerio L, Gallo A, et al. Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database: Vital registration data from 123 countries. Res Pract Thromb Haemost. 2021 Jun 15;5(5):e12520. doi: 10.1002/rth2.12520. eCollection 2021 Jul. | |
34233107 | 0 | Patriquin CJ, Laroche V, Selby R, et al. Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia. N Engl J Med. 2021 Aug 26;385(9):857-859. doi: 10.1056/NEJMc2109465. Epub 2021 Jul 7. | |
33405381 | 0 | Le Gal G, Carrier M, Castellucci LA, et al. Development and implementation of common data elements for venous thromboembolism research: on behalf of SSC Subcommittee on official Communication from the SSC of the ISTH. J Thromb Haemost. 2021 Jan;19(1):297-303. doi: 10.1111/jth.15138. | |
33174815 | 0 | Shoamanesh A, Patrice Lindsay M, Castellucci LA, et al. Canadian stroke best practice recommendations: Management of Spontaneous Intracerebral Hemorrhage, 7th Edition Update 2020. Int J Stroke. 2021 Apr;16(3):321-341. doi: 10.1177/1747493020968424. Epub 2020 Nov 11. | |
32759284 | 0 | Duffett L, Castellucci LA, Forgie MA. Pulmonary embolism: update on management and controversies. BMJ. 2020 Aug 5;370:m2177. doi: 10.1136/bmj.m2177. | |
32726824 | 0 | Giustozzi M, Castellucci LA, Barnes GD. Management of Anticoagulant Treatment and Anticoagulation-Related Complications in Nonagenarians. Hamostaseologie. 2020 Aug;40(3):292-300. doi: 10.1055/a-1174-1290. Epub 2020 Jul 29. | |
32645667 | 0 | Shaw JR, Carrier M, Dowlatshahi D, et al. Activated prothrombin complex concentrates for direct oral anticoagulant-associated bleeding or urgent surgery: Hemostatic and thrombotic outcomes. Thromb Res. 2020 Nov;195:21-28. doi: 10.1016/j.thromres.2020.06.044. Epub 2020 Jul 1. | |
32205598 | 0 | Fernando SM, Mok G, Castellucci LA, et al. Impact of Anticoagulation on Mortality and Resource Utilization Among Critically Ill Patients With Major Bleeding. Crit Care Med. 2020 Apr;48(4):515-524. doi: 10.1097/CCM.0000000000004206. | |
32125293 | 0 | Tritschler T, Castellucci LA, Van Es N, et al. Treatment of venous thromboembolism in elderly patients in the era of direct oral anticoagulants. Pol Arch Intern Med. 2020 Jun 6;130(6):529-538. doi: 10.20452/pamw.15225. Epub 2020 Mar 3. | |
31582557 | 0 | Stephen MS, Castellucci L, Carrier M, et al. Safety of using direct oral anticoagulants in the diagnostic workup of outpatients with suspicion of acute venous thromboembolism. Haematologica. 2020 Jun;105(6):e307-e309. doi: 10.3324/haematol.2019.232884. Epub 2019 Oct 3. | |
31226664 | 0 | Tritschler T, Castellucci LA. It's time for head-to-head trials with direct oral anticoagulants. Thromb Res. 2019 Aug;180:64-69. doi: 10.1016/j.thromres.2019.05.019. Epub 2019 May 31. | |
31092489 | 0 | Goldhar HA, O'Meara P, Castellucci LA. A case of antiphospholipid syndrome presenting cryptogenically as Budd-Chiari syndrome, then fulminantly as Libman-Sacks endocarditis. BMJ Case Rep. 2019 May 14;12(5). pii: 12/5/e227450. doi: 10.1136/bcr-2018-227450. | |
30327391 | 0 | Wang KL, van Es N, Cameron C, et al. Extended treatment of venous thromboembolism: a systematic review and network meta-analysis. Heart. 2019 Apr;105(7):545-552. doi: 10.1136/heartjnl-2018-313617. Epub 2018 Oct 16. | |
30046758 | 0 | Castellucci LA, de Wit K, Garcia D, et al. Extended anticoagulation for unprovoked venous thromboembolism. Res Pract Thromb Haemost. 2018 Jun 6;2(3):529-534. doi: 10.1002/rth2.12121. eCollection 2018 Jul. | |
29488097 | 0 | Chan TM, Jo D, Shih AW, et al. The Massive Online Needs Assessment (MONA) to inform the development of an emergency haematology educational blog series. Perspect Med Educ. 2018 Jun;7(3):219-223. doi: 10.1007/s40037-018-0406-0. | |
29324333 | 0 | Shaw JR, Castellucci L, Siegal D, et al. Management of direct oral anticoagulant associated bleeding: Results of a multinational survey. Thromb Res. 2018 Mar;163:19-21. doi: 10.1016/j.thromres.2018.01.008. Epub 2018 Jan 5. | |
27294776 | 0 | Castellucci LA, Shaw J, Giulivi A, et al. Determining the safety of enoxaparin prophylaxis in critically ill patients with severe renal insufficiency - The PACER pilot study. Thromb Res. 2016 Aug;144:69-71. doi: 10.1016/j.thromres.2016.05.026. Epub 2016 Jun 2. | |
26272305 | 0 | Castellucci LA, Shaw J, van der Salm K, et al. Self-reported adherence to anticoagulation and its determinants using the Morisky medication adherence scale. Thromb Res. 2015 Oct;136(4):727-31. doi: 10.1016/j.thromres.2015.07.007. Epub 2015 Jul 14. | |
25626038 | 0 | Castellucci LA, Wells PS, Duffett L. Nonleg venous thrombosis in critically ill adults. JAMA. 2015 Jan 27;313(4):411-2. doi: 10.1001/jama.2014.12496. |